Emerging role of microRNA-21 in colorectal cancer

Cancer Biomarkers : Section a of Disease Markers
Jun ZhaoGuohai Zhao

Abstract

Colorectal cancer (CRC) is one of the most common types of cancers worldwide. In spite of much progress in surgery, chemotherapy and molecular targeted therapy, the mortality rate has only decreased slightly over the past years. MicroRNAs are 18-25 nucleotide, noncoding RNA molecules that regulate the translation of many genes. Evidence suggests that miRNAs may play an important role in a variety of cellular biological processes, such as cell growth, differentiation, metabolism, invasion, angiogenesis. Recently, miR-21 is found to be aberrantly expressed in CRC and miR-21 has been recognized to perform significantly in CRC, where miR-21 can regulate several different target genes and pathways involving tumor proliferation, invasion and metastasis. In this study, we will focus on the critical role of miR-21 in CRC. Hopefully, the information obtained may lead to a better understanding of the pathogenesis and development of novel therapeutic strategies for this disease.

Citations

Dec 3, 2016·Journal of Applied Genetics·A A SazanovM I Zaraysky
Sep 8, 2017·International Journal of Molecular Sciences·Chih-Hau ChangYa-Ling Hsu
Apr 2, 2019·Scientific Reports·Nicholas J MonteleoneDan A Dixon
Oct 28, 2019·Journal of Cellular Physiology·Zohreh JahanafroozBehzad Baradaran
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wen-Jun WangCheng Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

© 2021 Meta ULC. All rights reserved